Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
68Ga-FAP-CHX PET/CT in Solid Tumors
NCT05506566Phase 2Unknown
- Sponsor
- The First Hospital of Fujian Medical University
- Start
- May 2022
- Primary completion
- May 2025
- Modality
- Radiopharmaceutical
- Countries
- 1
01
Overview
A Phase 2 trial of gallium ga 68 FAP-CHX in solid tumor, sponsored by The First Hospital of Fujian Medical University. Status: unknown.
02
Drugs
gallium ga 68 FAP-CHX
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT05506566.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05506566.